During hexamethylene bisactamide (HMBA)-induced dierentiation of murine erythroleukemia (MEL) cells erythroid genes are transcriptionally activated while cmyb and several other nuclear proto-oncogenes are down-regulated. Dierentiation is inhibited by cAMP analogues and the adenyl cyclase-stimulating agent forskolin. We found that these drugs prevented the late down-regulation of c-myb which is known to be critical for MEL cell dierentiation. Since the increase in c-myb mRNA levels was due to increased mRNA transcription, we examined the transcription factors NF-kB and AP-1 which have been implicated in the regulation of c-myb expression. Binding of MEL cell nuclear proteins to a NF-kB recognition sequence in c-myb intron I was strongly induced by 8-Br-cAMP or forskolin; induction was delayed and correlated with the up-regulation of cmyb. The cAMP-induced NF-kB complex contained p50 and RelB; in co-transfection assays, p50 and RelB transactivated a reporter construct containing the c-myb intronic NF-kB site upstream of a minimal promoter. 8-Br-cAMP and forskolin also increased the DNA binding activity of AP-1 complexes containing JunB, JunD and c-Fos in MEL cells which could cooperate with NF-kB. We conclude that inhibition of MEL cell dierentiation by pharmacological doses of cAMP can be explained by the up-regulation of c-myb which is mediated, at least in part, by NF-kB p50/RelB heterodimers.
Introduction
Friend virus-infected mouse erythroleukemia (MEL) 1 cells provide a valuable model system to study the molecular events leading to erythroid dierentiation. After exposure to agents like hexamethylene bisacetamide (HMBA) and dimethyl sulfoxide (DMSO), MEL cells transcriptionally activate erythroid-speci®c genes and produce large amounts of hemoglobin (Fraser and Curtis, 1987; Rifkind et al., 1987) . Speci®c changes in nuclear proto-oncogene transcription occur during the dierentiation of MEL cells including bi-phasic changes in c-myb mRNA levels: c-myb decreases within 4 h of adding an inducing agent (early down-regulation), recovers to basal levels by 24 h and then decreases again at 48 ± 72 h (late down-regulation). Forced overexpression of c-myb during the late, but not during the early down-regulation can completely block differentiation (Watson, 1988; McClinton et al., 1990; Clarke et al., 1988; Dmitrovsky et al., 1986; Danish et al., 1992) .
Both cAMP-dependent protein kinase (A-kinase) and protein kinase C are necessary for MEL cell dierentiation and ®nely regulated changes in the activity and isozyme pattern of these two protein kinases have been described during dierentiation (Pilz et al., 1992; Schwartz and Rubin, 1985; Melloni et al., 1989 Melloni et al., , 1990 . Paradoxically, MEL cell dierentiation is inhibited when the cells are treated with cAMPanalogues or phorbol esters which activate A-kinase or protein kinase C, respectively (Yamasaki et al., 1977; Mignotte et al., 1990; Sherman et al., 1986 Sherman et al., , 1988 . These ®ndings suggest that cAMP analogues and phorbol esters induce immediate and prolonged signals which are not compatible with the ®ne changes in gene expression required for dierentiation. For example, cAMP analogues and phorbol esters can modulate the activity of the transcription factors NFkB and AP-1 which have been implicated in the regulation of c-myb and play an important role in hematopoietic cell dierentiation (Angel and Karin, 1991; Toth et al., 1995; Siebenlist et al., 1994; Nicolaides et al., 1992; Weih et al., 1995; Prochownik et al., 1990) . Members of the NF-kB/rel family of transcriptional regulators include RelA/p65, RelB, cRel and p50; the latter is derived from its precursor p105 by proteolytic cleavage (Miyamoto and Verma, 1995) . As homo-or heterodimers, the rel-related proteins interact with dierent decameric DNA motifs present in the promoter/enhancer regions of many genes including c-myb (Toth et al., 1995) . The transcription factor complex AP-1 is composed of jun-and fos-related proteins and is down-regulated during HMBA-induced dierentiation of MEL cells; dierentiation is severely inhibited by overexpression of jun-related proteins (Prochownik et al., 1990; Mignotte et al., 1989; Talbot et al., 1990; Garingo et al., 1995) .
To better understand the mechanism(s) by which pharmacological activation of A-kinase inhibits erythroid dierentiation, we decided to study the eect of cAMP analogues on MEL cell dierentiation and compare it to the eect of forskolin, which increases the intracellular cAMP concentration by stimulating endogenous adenyl cyclase activity (Moudry and Porzig, 1990) . We found that cAMP analogues and forskolin largely prevented the HMBA-induced in-crease in erythroid-speci®c gene expression and the late down-regulation of c-myb. The drugs induced a NF-kB complex which bound to a recognition site present in intron I of c-myb and contained p50 and RelB. Cotransfection of p50 and relB expression vectors resulted in transactivation of a reporter construct containing this c-myb NF-kB binding site. These results together with the kinetics of NF-kB induction by cAMP suggested that NF-kB, possibly in cooperation with other transcription factors, mediates the up-regulation of c-myb which in turn blocks erythroid dierentiation (McClinton et al., 1990; Clarke et al., 1988) .
Results

Inhibition of HMBA-induced dierentiation of MEL cells by cAMP analogues and forskolin
After culturing MEL cells in serum-free medium in the presence of 2.5 mM HMBA for 4 days, hemoglobin production was detectable by benzidine staining in approximately 85% of the cell population whereas less than 1% of cells cultured in the absence of HMBA contained detectable hemoglobin ( Figure 1a ). Hemoglobin production in the presence of HMBA was inhibited by about 70% when cells were treated with the membrane-permeable cAMP analogues 8-Br-cAMP (1.25 mM), 8-Cl-cAMP (50 mM), 8-CPT-cAMP (0.25 mM) or forskolin (12 mM), a stimulator of adenyl cyclase activity. The drug concentrations shown were those which caused maximal inhibition of hemoglobin production without impairment of cell viability; dierent concentrations of each drug were required because of dierences in drug potency, membrane permeability and resistance to phosphodiesterase breakdown with similar drug concentrations having been used in other leukemic cell lines (Beebe and Corbin, 1986; Rohl et al., 1993; Lanotte et al., 1991; Scheele et al., 1994) . Forskolin has been shown to increase the intracellular cAMP concentration 4100-fold in MEL cells (Moudry and Porzig, 1990) . Previous workers showed inhibition of DMSO-induced hemoglobin production in MEL cells treated with 1 mM dibutyryl-cAMP or with cAMP-elevating agents like theophylline, phenylisopropyl-adenosine, prostaglandin E 1 or E 2 , with a strong correlation between the cAMP levels achieved and the degree of inhibition of hemoglobin production observed (Sherman et al., 1986 (Sherman et al., , 1988 . However, the mechanism of this inhibition was not further investigated.
When MEL cells are induced to dierentiate by HMBA, erythroid genes are transcriptionally activated resulting in the accumulation of mRNAs encoding bglobin and the erythroid-speci®c d-aminolevulinate (d-ALA) synthetase, a key enzyme involved in heme synthesis (Fraser and Curtis, 1987; Pilz, 1993) . In untreated cells, b-globin and d-ALA-synthetase mRNAs were barely detectable but both mRNA levels increased more than 20-fold in cells cultured in the presence of HMBA (Figure 1b, lanes 1 and 2) . The HMBA-induced increase in b-globin and d-ALAsynthetase mRNA was largely prevented in cells treated with 8-Br-cAMP or forskolin (Figure 1b, lanes  3 and 4) , correlating with the observed inhibition of hemoglobin synthesis (Figure 1a) . Figure 1 Eect of cAMP analogues and forskolin on HMBAinduced dierentiation: inhibition of hemoglobin production and b-globin and d-ALA-synthetase mRNA expression. MEL cells were cultured in serum-free media in the absence or presence of 2.5 mM HMBA as described in Materials and methods. (a) Hemoglobin production was assessed after 4 days of culture by determining the percentage of cells that stained positive with benzidine (in the absence of HMBA 51% of cells were positive). The indicated drugs were added together with HMBA at the following concentrations: 8-Br-cAMP, 1.25 mM; 8-Cl-cAMP, 50 mM; 8-CPT-cAMP, 0.25 mM; and forskolin, 12 mM. The data are the mean+s.d. of three independent experiments performed in duplicate. (b) Cytoplasmic RNA was extracted after 3 days of culture in the absence of HMBA (lane 1), in the presence of HMBA (lane 2), in the presence of HMBA plus 1.25 mM 8-BrcAMP (lane 3) or in the presence of HMBA plus 12 mM forskolin (lane 4). A Northern blot was hybridized to cDNA probes for bglobin, erythroid-speci®c d-ALA synthetase or CHO-A as described in Materials and methods; the probe for the structural protein CHO-A was used to assess for equal loading and transfer of RNA. In the absence of HMBA, the signals for b-globin and d-ALA-synthetase were detectable upon longer exposure of the autoradiographs (not shown) returns to pre-induction levels by 24 h and decreases again at 48 ± 72 h to remain at low levels for the duration of the dierentiation process (Watson, 1988; Coppola et al., 1989) . c-myc mRNA levels show similar changes up to 24 h after induction, but in contrast to c-myb, c-myc mRNA level remains stable thereafter (Watson, 1988; Coppola et al., 1989) . Deregulated and continuous expression of c-myb or c-myc has been shown to block dierentiation of erythroid and myeloid cells (Rosson and O'Brien, 1995; Liebermann and Homan, 1994; Todokoro et al., 1988; Clarke et al., 1988; Dmitrovsky et al., 1986) . Transfection of MEL cells with constructs that allowed c-myb expression from conditional promoters showed that up-regulation of c-myb during the ®rst 24 h had no eect whereas later up-regulation of c-myb blocked dierentiation, suggesting that the late down-regulation of c-myb is critical for dierentiation (McClinton et al., 1990; Danish et al., 1992) .
To examine the eect of 8-Br-cAMP and forskolin on the expression of c-myb mRNA, we cultured MEL cells with HMBA in the presence or absence of 8-BrcAMP or forskolin and isolated RNA at various times for Northern blot analysis. During the ®rst 24 h after adding HMBA, we found that the regulation of c-myb mRNA was the same in the absence or presence of 8-Br-cAMP or forskolin; however, 8-Br-cAMP and forskolin prevented the late down-regulation of c-myb in HMBA-treated cells (Figure 2a shows results at 4, 24 and 72 h). The regulation of c-myc mRNA expression in the HMBA-induced MEL cells was not altered by 8-Br-cAMP or forskolin (data not shown).
The expression of c-myb in dierentiating MEL cells is regulated by increased mRNA turnover and premature transcription arrest; the destabilization of c-myb mRNA is most noticeable during the early down-regulation of c-myb whereas the late downregulation of c-myb is primarily due to a block in transcriptional elongation in the ®rst intron (Watson, 1988) . To examine whether cAMP altered the stability of c-myb mRNA, we added Actinomycin D (5 mg/ml) to cells that had been cultured for 72 h with HMBA in the absence or presence of 1.25 mM 8-Br-cAMP. Northern blots of RNA extracted 30 min to 4 h after adding Actinomycin D showed that c-myb mRNA levels declined with a similar half-life (about 2 h) in cells treated with HMBA plus 8-Br-cAMP as in cells treated with HMBA only. The 2 h half-life of c-myb mRNA was similar to that reported for DMSO-treated MEL cells (Watson, 1988) . To examine whether the eect of cAMP on c-myb mRNA occurred at the transcriptional level, we performed`nuclear run-o' analyses. Intact nuclei were isolated from MEL cells cultured for 72 h in the presence or absence of 8-BrcAMP and/or HMBA and the nuclei were incubated in the presence of [a 32 PO 4 ]UTP to measure relative rates of transcriptional elongation of pre-initiated RNA chains (Figure 2b ). Hybridization of nuclear RNA transcripts to a genomic probe encoding c-myb sequences 3' of intron I was detected in untreated MEL cells, but this signal disappeared in HMBAtreated cells. These results suggest decreased c-myb transcriptional elongation in HMBA-treated MEL cells corresponding to the block in c-myb transcriptional elongation previously demonstrated in DMSO-treated MEL cells (Watson, 1988) . Addition of 8-Br-cAMP to HMBA-treated cells increased the amount of nuclear RNA hybridizing to the c-myb probe, suggesting that cAMP increased c-myb mRNA expression at the transcriptional level.
Eect of 8-Br-cAMP and forskolin on protein binding to c-myb intron I sequence Transcriptional regulation of the c-myb gene occurs through a conditional block to transcriptional elongation in the ®rst intron of the gene and has been mapped to a 1 kb region near a major DNase Northern blots were hybridized to a c-myb probe as described in Materials and methods; blots were stripped and re-hybridized to a CHO-A probe to assess RNA loading and transfer. (b) Cells were cultured for 72 h in the absence of drugs (Control), in the presence of 2.5 mM HMBA or in the presence of 2.5 mM HMBA plus 1.25 mM 8-Br-cAMP (HMBA+cAMP). Intact nuclei were isolated and nuclear run-o transcription analyses were performed as described in Materials and methods. Nuclear RNA (2610 7 trichloroacetic acid-precipitable c.p.m.) was hybridized to the following DNA probes immobilized on nylon membranes: a cDNA probe encoding the structural protein CHO-A (CHOA); a genomic probe encoding c-myb sequences 3' of intron I (c-myb); pGem3Z vector DNA to control for nonspeci®c hybridization (pGem); and a cDNA probe encoding bglyceraldehyde-3-phosphate dehydrogenase (GAPD) hypersensive site and several sites of protein/DNA interaction [ (Watson, 1988; Toth et al., 1995; Reddy and Reddy, 1989) and Figure 3 ]. Two consensus sequences for the transcription factor NF-kB¯ank the site of transcriptional block in c-myb intron I; several NF-kB-related proteins were shown to bind to these sequences and transactivate a Myb/CAT reporter construct (Toth et al., 1995) .
Since A-kinase activation can alter NF-kB activity in some cell types (Siebenlist et al., 1994) , we examined DNA binding of NF-kB in MEL cells cultured with HMBA in the presence or absence of 8-Br-cAMP or forskolin. We used oligodNT's encoding two very dierent NF-kB consensus sequences: NF-kB/myb which is derived from c-myb intron I (the NF-kB site b present in fragment II, Figure 3 ), and NF-kB/Igk which is derived from the immunoglobulin k light chain enhancer (Toth et al., 1995) . Nuclear extracts from MEL cells cultured in the presence or absence of HMBA formed several speci®c complexes when incubated with either oligodNT (NF-kB/myb is shown in Figure 4a , NF-kB/Igk is shown in Figure 4b ). In the presence of 8-Br-cAMP or forskolin, one of these complexes was strongly induced; this induction was barely detectable at 16 h and maximal at 3 days ( 
Analysis of the cAMP-induced protein complex bound to the NF-kB/c-myb oligodNT
To examine the composition of the cAMP-induced protein/DNA complex formed with the NF-kB-myb oligodNT, we incubated nuclear extracts obtained after 3 days of drug exposure with antibodies speci®c for p105/p50, RelA/p65 or with control IgG. The cAMPinduced complex was shifted to a higher molecular weight (`supershifted') in the presence of p50 antibody ( Figure 5a ). The protein/DNA complexes observed in the presence of RelA/p65 antibody were indistinguishable from the complexes seen in the presence of control IgG, although the antibody was shown to`supershift' murine RelA/p65 in NF-kB/DNA complexes in control experiments (described in Materials and methods). Antibodies speci®c for RelB and c-Rel did not supershift' murine RelB and c-Rel eciently but recognized the proteins on Western blots. We, therefore, examined the cAMP-induced NF-kB complex for the presence of these proteins using a dierent approach: we excised the cAMP-induced complex from the EMSA gel, separated the proteins by SDS ± PAGE and performed Western blots. Although this method did not allow accurate quantitation of proteins, it demonstrated that the cAMP-induced complex contained RelB ( Figure 5b) ; RelA/p65 and c-Rel were not detected. We conclude that the cAMPinduced NF-kB complex contains p50 and RelB; it may also contain heterodimers of p50 with other Rel-related proteins but at levels below the limit of our detection.
Eect of 8-Br-cAMP and forskolin on the expression and subcellular localization of NF-kB subunits Next, we examined the eect of 8-Br-cAMP and forskolin on the expression and subcellular localization of NF-kB subunits in dierentiating MEL cells using Western blots of cytosolic and nuclear proteins (Figure 6a ). p105/p50, RelB, RelA/p65 and c-Rel were present in cytosolic extracts; the amount of p105/p50 and RelB was increased in 8-Br-cAMP-or forskolintreated cells (compare lanes 3 and 4 to lane 2, left half of Figure 6a ). Nuclear extracts of untreated or HMBAtreated cells contained detectable amounts of RelB and RelA/p65, but little p50 or c-Rel (lanes 1 and 2, right half of Figure 6a ). In response to 8-Br-cAMP or forskolin, the amount of nuclear p50 and RelB increased signi®cantly (compare lanes 3 and 4 to lane 2, right half of Figure 6a) ; control experiments showed Figure 3 Schematic representation of the murine c-myb intron I. The region of transcriptional pause, DNAse hypersensitive sites and restriction enzyme cleavage sites are indicated (Reddy and Reddy, 1989) . Two NF-kB binding sites (Toth et al., 1995) are indicated as black boxes and several putative AP-1 binding sites (Reddy and Reddy, 1989) are indicated as ovals. Restriction fragments used in EMSA competition experiments are labeled I-IV. Fragment II, a 150 bp BglII/BamHI fragment containing the NF-kB binding site b, was used to construct the reporter construct pNFkB-CAT that this increase was not due to the contamination of nuclear extracts with cytosolic proteins (described in Materials and methods). Speci®city of the p105/p50 antibody was veri®ed by peptide blocking experiments: in addition to p50 and p105, two minor bands detected by the antibody were competed by control peptide. The minor bands may represent alternative splice products derived from the murine p105 gene which include IkB-g (Grumont and Gerondakis, 1994) .
Northern blots showed that 8-Br-cAMP or forskolin strongly induced p105/p50 and relB mRNA expression, whereas the levels of relA/p65 and c-rel mRNA were unchanged (Figure 6b ). Taken together, our data suggest that cAMP increases the amount of p50 and RelB protein by increasing transcription, processing or stability of p50 and relB mRNA.
Eect of NF-kB subunits on expression of a reporter construct containing the intronic c-myb NF-kB binding site b Toth et al. (1995) found that co-transfection of p50 plus relA/p65 or RelA/p65 plus c-rel into NF-kBde®cient murine thymoma cells resulted in transactivation of a pMyb/CAT reporter construct whereas transfection of single NF-kB subunits did not; deletion of both NF-kB recognition sites in the c-myb intron I abrogated the eect. However, expression of the reporter gene from pMyb/CAT did not correlate with expression of endogenous c-myb mRNA in dierent cell lines including MEL cells (M Suhasini, unpublished observation) .
To determine whether the c-myb intronic NF-kB site b can act as an enhancer element which is inducible by p50 and/or RelB, we used a simple reporter construct in which the NF-kB site-containing BglII/BamHI fragment of c-myb intron I (fragment II, Figure 3 ) was placed upstream of a minimal thymidine kinase promoter and CAT reporter gene. We transfected this reporter together with expression vectors for dierent NF-kB subunits into Baby Hamster Kidney (BHK) cells which contain little endogenous NF-kB activity. Co-transfection of an expression vector for p105 or relB increased CAT expression 2-and 5.8-fold, respectively; co-transfection of p105 plus relB resulted in tenfold stimulation of CAT activity (Figure 7 ). For comparison, co-transfection of relA/p65 alone had no eect whereas relA/p65 plus p105 resulted in a 2.8-fold stimulation of CAT activity. CAT expression from the parent vector pBL-CAT2 lacking NF-kB binding sites was not in¯uenced by any combination of NF-kB subunits. These results indicate that the NF-kB site b present in fragment II of c-myb intron I can act as an enhancer element which is dierentially regulated by PO 4 -labeled oligodNT probe encoding the NF-kB recognition site of the immunoglobulin k light chain enhancer (NF-kB/Igk). The unlabeled competitor DNAs were as described above. Equal loading and quality of nuclear extracts were demonstrated in control EMSAs using an oligodNT recognized by the ubiquitous transcription factor SP-1 (not shown) NF-kB Induction and c-myb up-regulation by cAMP M Suhasini et al dierent NF-kB complexes. Similar transfection experiments performed in MEL cells showed a 2 ± 3-fold transactivation of the pNFkB-CAT reporter by cotransfection of p50 and relB, probably because of higher endogenous p50 and RelB levels in MEL cells. The eect of cAMP on the transcriptional activity of the pNFkB-CAT reporter in MEL cells could not be assessed, because the parent vector pBL-CAT2 contains cryptic cAMP-responsive elements (Ghersa et al., 1994, and M Suhasini, unpublished 
observation).
Eect of 8-Br-cAMP and forskolin on the DNA binding activity of AP-1 and analysis of the AP-1 complex
In MEL cells AP-1 DNA binding activity is downregulated within 6 ± 12 h after adding HMBA and remains low throughout the dierentiation process [(Garingo et al., 1995; Talbot et al., 1990) and Figure  8a ]. Constitutive overexpression of jun family members or induction of AP-1 by phorbol esters results in a block of MEL cell dierentiation (Prochownik et al., 1990; Yamasaki et al., 1977) . The murine c-myb intron I contains several putative AP-1 binding sites and transactivation of the human c-myb promoter by jun family members has been reported (Reddy and Reddy, 1989; Nicolaides et al., 1992) . Since activation of the cAMP signal transduction pathway increases the expression of junB and c-fos mRNA leading to increased AP-1 activity in many cell types (Angel and Karin, 1991), we decided to examine the eect of 8-BrcAMP and forskolin on the DNA binding activity of AP-1 in HMBA-treated MEL cells. Exposing HMBAtreated MEL cells to 8-Br-cAMP or forskolin for only 1 h caused a signi®cant increase in the binding of nuclear proteins to a synthetic AP-1 recognition site (Figure 8a ; compare lane 2, HMBA-treated cells, to lanes 3 and 4, HMBA-treated cells cultured in the presence of 8-Br-cAMP or forskolin, respectively). Increased DNA binding of AP-1 in the presence of 8-Br-cAMP or forskolin was maximal at 6 h; a smaller eect persisted for 3 days. The HMBA-induced decrease in AP-1 DNA binding on day 3 was completely abrogated in the presence of 8-Br-cAMP or forskolin (Figure 8a ).`Supershift' assays showed that the AP-1/DNA complex induced by cAMP contained JunB, JunD and c-Fos protein (Figure 8c) . Like previous workers, we found that MEL cells do not express detectable levels of c-Jun protein (Francastel et al., 1994) .
The protein/DNA complexes observed with the AP-1 oligodNT were eciently competed by adding a 50-fold excess of the unlabeled oligodNT (Figure 8b , compare lanes 1 and 2). However, no speci®c competition was observed when we added a 50-fold molar excess of restriction fragments I-IV of c-myb intron I (Figure 3 ) of which fragments I, III and IV contain putative AP-1 recognition sites (Figure 8b , lanes 3 ± 6). These experiments and others performed with oligodNTs corresponding to putative AP-1 recognition sites of c-myb intron I (Reddy and Reddy, 1989) did not demonstrate binding of AP-1 to intronic sequences of c-myb. However, these results do not exclude cooperation of AP-1 with NF-kB in the regulation of c-myb expression, because Stein et al. (1993a) demonstrated that AP-1 can directly interact with NF-kB and potentiate transactivation via NF-kB enhancer elements. Moreover, transactivation of the human c-myb promoter by junD has been reported (Nicolaides et al., 1992) .
Eect of 8-Br-cAMP and forskolin on the DNA binding of NF-E2, GATA-1 and SP-1
To determine whether cAMP treatment of MEL cells in¯uenced the DNA binding of other transcription factors, we examined DNA binding of NF-E2, GATA-1 and SP-1 in HMBA-treated MEL cells cultured in the absence or presence of 1.25 mM 8-Br-cAMP. We found that short-term exposure (1 ± 6 h) to the drug did not change DNA binding of these three transcription factors. After 16 h of culture in HMBA plus 8-BrcAMP, we found a modest increase in NF-E2/DNA complexes which persisted for 3 days; DNA binding of GATA-1 and SP-1 was not altered by 8-Br-cAMP at these later times (data not shown).
Discussion
The study of drugs which inhibit erythroid differentiation has elucidated some of the molecular events involved in the regulation of dierentiation. For example, inhibition of MEL cell dierentiation by glucocorticoids correlates with inhibition of GATA-1 function and prevention of the late down-regulation of c-myb (Chang et al., 1993; Ramsay et al., 1986) . Erythroid dierentiation of MEL cells and of the human erythroleukemia line K562 is inhibited by the phorbol ester TPA (Yamasaki et al., 1977; Mignotte et al., 1990) ; in the latter cell line, suppression of erythroid gene expression by TPA is associated with decreased DNA binding of GATA-1 and NF-E2 while DNA binding of AP-1 is increased (Solomon et al., 1993) . Using a de®ned serum-free culture system, we found that treatment of MEL cells with cAMP analogues and forskolin inhibits HMBA-induced hemoglobin production because the drugs suppressed HMBA-induced expression of erythroid-speci®c genes and interfered with the normal regulation of c-myb. The importance dierentiation and it has a de-dierentiating eect on transformed myeloid cells (Luscher and Eisenman, 1990; Clarke et al., 1988; Liebermann and Homan, 1994) . It is clear that the late down-regulation of c-myb 5, 8, 11 ) or in the presence of HMBA plus 8-Br-cAMP (lanes 3, 6, 9, 12). EMSAs were performed with labeled AP-1 oligodNT as described in Materials and methods after preincubation of nuclear extracts with control IgG (lanes 1 ± 3) , JunB-speci®c antibody (lanes 4 ± 6), JunD-speci®c antibody (lanes 7 ± 9) or c-Fos-speci®c antibody (lanes 10 ± 12). Supershifted complexes are indicated by asterisks is essential for the dierentiation of MEL cells (Danish et al., 1992; Todokoro et al., 1988; McClinton et al., 1990) . Introduction of a truncated form of c-myb into MEL cells accelerates dierentiation and it has been hypothesized that the truncated c-myb which lacks transcriptional regulatory regions may act in a dominant negative fashion (Introna et al., 1994; Weber et al., 1990) . Thus, c-myb may suppress the transcription of dierentiation-promoting genes and/or it may positively regulate genes that are incompatible with the dierentiation of erythroid and myeloid cells. Some hematopoietic-speci®c target genes which are regulated by c-myb have been recently identi®ed (Melotti and Calabretta, 1996) .
Transcription of c-myb mRNA is predominantly controlled by a conditional block in transcriptional elongation which occurs in the center of intron I [ Figure 3 , (Watson, 1988; Toth et al., 1995) ]. A major DNase hypersensitive site maps near the transcriptional block and is more intense in cells with low c-myb mRNA expression (Toth et al., 1995) . DNA binding studies have shown a direct correlation between the extent of sequence-speci®c protein binding to some fragments of c-myb intron I and c-myb mRNA levels in dierent cell types as well as in dierentiating MEL cells, suggesting that some nuclear factors may act as positive regulators of c-myb transcription; however, the nature of these factors was not further investigated (Reddy and Reddy, 1989) . Toth et al. (1995) identi®ed two conserved NF-kB binding sites¯anking the site of transcriptional attenuation in intron I of the human and murine c-myb gene and showed transactivation of a Myb/CAT reporter construct containing the promoter and intron I of c-myb by co-transfection of p65 plus c-rel or p50 plus p65. Paradoxically, these authors found an inverse correlation between the amount of protein bound to the c-myb NF-kB site and the amount of c-myb mRNA expressed in dierent B-cell lines; they hypothesized that cooperation of NF-kB with other transcription factors may be necessary for NF-kB to transactivate c-myb in vivo (Toth et al., 1995) . Functional synergy between NF-kB and the basic leucine zipper transcription factors AP-1 and C/ EBP has been described which required only NF-kB to bind DNA (Stein et al., 1993a,b) ; interestingly, the activities of AP-1 and C/EBP-b are regulated by the cAMP signal transduction pathway (Angel and Karin, 1991; Metz and Zi, 1991) . In MEL cells, we found no dierence in NF-kB binding between untreated and HMBA-treated MEL cells; thus, NF-kB does not appear to be involved in the maintenance of high cmyb mRNA levels in undierentiated cells. However, we found that the induction of p50-and RelBcontaining NF-kB complexes by cAMP positively correlated with increased expression of c-myb mRNA and showed that p50 and relB strongly transactivated a reporter gene depending on the presence of fragment II with the NF-kB binding site b of c-myb intron I (Figure 3) . Moreover, recent experiments have shown that stable overexpression of RelB plus p50 together but not of either protein alone resulted in inhibition of hemoglobin synthesis and up-regulation of c-myb mRNA levels in HMBA-treated MEL cells (manuscript in preparation). Thus, RelB/p50 complexes can positively regulate endogenous c-myb expression in these cells.
Induction of NF-kB DNA binding activity by cAMP has been previously observed in the human promyelocytic cell line HL-60; as compared to NF-kB induction by lipopolysaccharide, induction by cAMP was delayed, with a threefold increase in DNA binding activity detected after 6 h (Serkkola and Hurme, 1993) . Induction of NF-kB DNA binding by cAMPanalogues and cAMP-increasing agents has also been reported in murine macrophages and in the human NK-like lymphoid line YT, where increased NF-kB DNA binding occurs within 1 ± 4 h and correlates with increased phosphorylation of IkB; however, the nature of the cAMP-induced NF-kB/DNA complexes was not examined (Shirakawa and Mizel, 1989; Muroi and Suzuki, 1993) . Many NF-kB activating signals result in inactivation of one of the IkB-like proteins which normally sequester NF-kB subunits in the cytoplasm and inhibit NF-kB DNA binding. Phosphorylation of IkB-a, -b and -g by A-kinase results in de-stabilization of the inhibitory protein, release of NF-kB inhibition and nuclear translocation of NF-kB (Shirakawa and Mizel, 1989; Gerondakis et al., 1993) . In addition, most members of the NF-kB family contain a conserved recognition sequence for A-kinase and phosphorylation of p65 by A-kinase has been shown to occur in vivo and result in the stimulation of NF-kB transcriptional activity (Zong et al., 1997; Miyamoto and Verma, 1995) . In phorbol ester-treated T-lymphoblasts, increased p105/p50 phosphorylation correlates with increased proteolytic processing of p105 and increased DNA binding activity of p50 (MacKichan et al., 1996; Li et al., 1994) . However, the delayed kinetics of NFkB induction by cAMP in MEL cells argue against post-translational modi®cation of pre-existing proteins as the only mechanism of NF-kB induction. Our results suggest that cAMP increases the synthesis of p50 and RelB proteins by increasing the amount of p105/p50 and relB mRNA. The p105/p50 and relB genes are known to be serum-, phorbol ester-and growth factor-inducible, but the promoters of the murine genes have not been studied (Olashaw, 1996; Ryseck et al., 1992) .
In conclusion, pharmacologic activation of A-kinase in MEL cells induces p50 and RelB binding to a NFkB recognition site in c-myb intron I and the data suggest that NF-kB, possibly in cooperation with other transcription factors, increases c-myb expression; inappropriate expression of c-myb is known to block erythroid dierentiation of MEL cells (Danish et al., 1992; Todokoro et al., 1988; McClinton et al., 1990) . Interestingly, among the hematopoietic abnormalities seen in RelB-de®cient transgenic mice is splenomegaly due to extramedullary hematopoiesis and erythroid hyperplasia, suggesting that RelB might play a negative regulatory role during normal erythroid dierentiation (Weih et al., 1995) .
Materials and methods
Materials
The cAMP analogues were from Boehringer Mannheim, forskolin was from Sigma and radiochemicals were from New England Nuclear. Polyclonal antibodies speci®c for p105/p50, RelA/p65, RelB, JunB, JunD and c-Fos and control rabbit IgG were from Santa Cruz Biotechnology; a c-Rel-speci®c antibody was a generous gift of Nancy Rice (Rice et al., 1992) . Double-stranded oligodeoxynucleotide (oligodNT) probes encoding the NF-kB consensus sequence of the immunoglobulin light chain enhancer or a synthetic AP-1 consensus sequence were from Promega. OligodNTs encoding the NF-kB consensus sequence b of cmyb intron I or encoding putative AP-1 consensus sequences of c-myb intron I were synthesized by the UCSD Cancer Center Core Facility; they were annealed and puri®ed by polyacrylamide gel electrophoresis (Reddy and Reddy, 1989) .
Plasmids
The DNA probes used for Northern blots and nuclear runo analyses were described previously Garingo et al., 1995; Pilz et al., 1993; Rice et al., 1992; Mercurio et al., 1993; Ryseck et al., 1992) . The reporter plasmid pNFkB-CAT was constructed by ligating a 150 bp BglII/BamHI fragment containing the NF-kB recognition site b of c-myb intron I (fragment II of Figure 3 ) into the BamHI site of pBL-CAT2 (Luckow and SchuÈ tz, 1987) . The presence of two tandem repeats of fragment II upstream of the minimal thymidine kinase promoter was con®rmed by restriction endonuclease mapping and DNA sequencing. Expression vectors for p105/p50 and relA/p65 were described previously; similarly, the vector for relB expression was constructed by ligating a 2.1 kB HindIII/ NotI fragment containing the murine relB coding sequence (provided by R Bravo) into the vector pRC/CMV (Ryseck et al., 1992; Mercurio et al., 1993) .
Cell culture and benzidine staining MEL cells (strain 745A) were routinely grown in Iscove's Modi®ed Dulbecco's Medium (IMDM) supplemented with 10% transferrin-enriched newborn calf serum. Most experiments were performed in DME/F12-based serumfree medium supplemented with 1 mg/ml bovine serum albumin, 12 mg/ml cholesterol, 5 mg/ml insulin, 5 mg/ml transferrin and 5 ng/ml sodium selenite as described previously (Eldridge and Dailey, 1992) ; however, similar results were obtained in IMDM supplemented with 10% heat-inactivated serum. Cells were transferred to the experimental medium for 12 ± 16 h prior to adding 2.5 mM HMBA and cAMP analogues or forskolin as indicated. Only cultures with 490% cell viability, as determined by trypan blue exclusion, were analysed. Benzidine staining for the presence of hemoglobin was performed as described previously (Pilz et al., 1992) . Baby Hamster Kidney (BHK) cells were maintained as described (Gudi et al., 1996) .
Northern blot analysis
Total cellular RNA was isolated, electrophoresed on 1% denaturing formaldehyde/agarose gels and transferred to nylon membranes; the blots were hybridized to 32 PO 4 -labeled probes as described previously (Garingo et al., 1995; Pilz et al., 1995) . The CHO-A cDNA probe was used as a control for equal RNA loading and transfer (Garingo et al., 1995) .
Nuclear run-o transcription analysis
Intact nuclei were prepared and RNA chain elongation was measured as described previously (Pilz, 1993) . [a-32 PO 4 ] UTP-labeled nuclear RNA (2610 7 c.p.m.) was hybridized to denatured DNA probes immobilized on nylon membranes as described (Pilz, 1993) .
Transfection experiments
BHK cells were transfected as described previously (Gudi et al., 1996) with 150 ng of pNFkB-CAT, 10 ng of pRSVLuc (serving as an internal control for transfection eciency) and 225 ng of the indicated NF-kB expression vector or`empty' control vector; the total amount of transfected DNA was kept constant at 610 ng by the inclusion of`empty' vector. Western blots of transfected BHK cells demonstrated comparable expression levels of RelA/p65, RelB and p105 with proper processing of p105 to p50.
Electrophoretic mobility shift assays (EMSAs)
Nuclear extracts were prepared from 2610 7 cells and 10 mg of protein were incubated with 10 fmol (10 4 c.p.m.) of endlabeled, double-stranded oligodeoxynucleotide (oligodNT) probes containing recognition sequences for NF-kB, AP-1, NF-E2/AP-1, GATA-1 or SP-1 as previously described (Garingo et al., 1995) . The oligodNTs had the following sequences (sense strand): NF-kB/Igk, 5'-AGT TGA GGG GAC TTT CCC AGG C-3' (Toth et al., 1995) ; NF-kB/ myb, 5'-GGC CTC TGG AAA GTA CCT TAA ACA TA-3' (Toth et al., 1995) ; AP-1 oligodNT, 5'-TTC CGG CTG ACT CAT CAA GCG-3' (Lee et al., 1987) ; NF-E2/ AP-1, 5'-TCC TCC AGT GAC TCA GCA CAG GTT CC-3' (Garingo et al., 1995) ; GATA-1, 5'-ATC TCC GGG CAA CTG ATA AGG ATT CCC T3' (Garingo et al., 1995) ; and SP-1, 5'-ATT CGA TCG GGG CGG GGC GAG C-3' (Garingo et al., 1995) . For`supershift' assays, nuclear extracts were preincubated for 30 min on ice with 2 mg of the indicated rabbit polyclonal antibodies or with control rabbit IgG . Protein/DNA complexes were resolved by non-denaturing polyacrylamide gel electrophoresis (PAGE) and autoradiography (Garingo et al., 1995) . In control experiments with nuclear extracts of phorbol ester-stimulated 70Z/3 cells (Liou et al., 1994) and serum-stimulated NIH3T3 cells (Ryseck et al., 1992) , the RelA/p65 antibody supershifted a protein/DNA complex formed with the NF-kB/Igk oligodNT under the conditions used; however, we were unable to demonstrate convincing supershifts with the available RelB-and c-Relspeci®c antibodies.
Western blot analysis
Approximately 10 7 cells were lysed in hypotonic buer and centrifuged for 1 min at 11 000 g to separate a nuclear and cytosolic fraction; nuclei were washed prior to extracting in high-salt buer as described (Garingo et al., 1995) . Equal amounts of cytosolic and nuclear extract proteins were separated by denaturing SDS ± PAGE and Western blots were prepared as previously described using chemiluminescence detection (Garingo et al., 1995) . All primary antibodies were used at a 1 : 1000 dilution with 70Z/3 cells or BHK cells transfected with the appropriate NF-kB subunit serving as positive controls. The p105/p50 antibody was raised against a peptide encoding the nuclear localization signal of p105/p50 and reacted with several cellular proteins; preincubation of this antibody with excess control peptide speci®cally competed antibody binding to all four bands shown in Figure 6a (data not shown). To determine whether nuclear extracts were contaminated with cytosolic proteins, some Western blots were developed with an antibody speci®c for the cytosolic protein RasGAP (Trahey and McCormick, 1987) . Only on prolonged exposures were traces of the 120 kDa protein detected in lanes with nuclear extracts; laser scanning of the signal indicated that nuclear extracts were contaminated with 53% of cytosolic proteins.
In some experiments, EMSAs were performed with the NF-kB/myb oligodNT as described above and the cAMP-induced NF-kB complex was excised from the nondenaturing gel. Protein/DNA complexes derived from 45 mg of nuclear extract protein were pooled, denatured in boiling SDS-sample buer and separated on denaturing SDS ± PAGE side by side with extracts from BHK cells transfected with the appropriate NF-kB expression vector. Proteins present in the cAMP-induced NF-kB complex were examined on Western blots using the RelA/p65-, RelB-and c-Rel-speci®c antibodies.
Autoradiographs of EMSAs, Northern and Western blots shown in Results are from representative experiments; all experiments were repeated at least three times with similar results.
